US 11,925,645 B2
Enhanced caffeinated beverage composition
Hector L. Lopez, Cream Ridge, NJ (US); Tim N. Ziegenfuss, Chardon, OH (US); and Matthew Titlow, Carlsbad, CA (US)
Assigned to ORTHO-NUTRA, LLC, Morganville, NJ (US)
Filed by Ortho-Nutra, LLC, Morganville, NJ (US)
Filed on Feb. 21, 2023, as Appl. No. 18/172,021.
Application 18/172,021 is a continuation of application No. 17/084,777, filed on Oct. 30, 2020, granted, now 11,583,534.
Application 17/084,777 is a continuation in part of application No. 16/551,373, filed on Aug. 26, 2019, granted, now 11,426,410, issued on Aug. 30, 2022.
Application 16/551,373 is a continuation of application No. 15/600,371, filed on May 19, 2017, granted, now 10,398,701, issued on Sep. 3, 2019.
Application 15/600,371 is a continuation in part of application No. 14/539,726, filed on Nov. 12, 2014, granted, now 10,272,091, issued on Apr. 30, 2019.
Claims priority of provisional application 62/955,261, filed on Dec. 30, 2019.
Claims priority of provisional application 61/903,362, filed on Nov. 12, 2013.
Prior Publication US 2023/0190757 A1, Jun. 22, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/522 (2006.01); A23L 33/10 (2016.01); A23L 33/105 (2016.01); A61K 31/133 (2006.01); A61K 31/14 (2006.01); A61K 31/4748 (2006.01); A61K 31/685 (2006.01); A61K 31/7048 (2006.01); A61K 31/7068 (2006.01); C07D 487/04 (2006.01)
CPC A61K 31/522 (2013.01) [A23L 33/10 (2016.08); A23L 33/105 (2016.08); A61K 31/133 (2013.01); A61K 31/14 (2013.01); A61K 31/4748 (2013.01); A61K 31/685 (2013.01); A61K 31/7048 (2013.01); A61K 31/7068 (2013.01); C07D 487/04 (2013.01); A23V 2002/00 (2013.01)] 20 Claims
 
1. A caffeinated beverage composition supplemented with methylliberine and theacrine, the composition comprising:
a caffeinated drink having a caffeine content of between about 1 mg/oz to 65 mg/oz;
theacrine in an amount of between about 1.5 mg/oz to 15 mg/oz; and
methylliberine in an amount of between about 3.0 mg/oz to 30 mg/oz.